Historical Stock Price
AST historical stock prices picture
AST (AST) has the following price history information. Looking back at AST historical stock prices for the last five trading days, on March 27, 2019, AST opened at $0.94, traded as high as $0.94 and as low as $0.94, and closed at $0.94. Trading volume was a total of 0 shares. On March 28, 2019, AST opened at $0.94, traded as high as $0.94 and as low as $0.94, and closed at $0.94. Trading volume was a total of 0 shares. On March 29, 2019, AST opened at $0.94, traded as high as $0.94 and as low as $0.94, and closed at $0.94. Trading volume was a total of 0 shares. On April 01, 2019, AST opened at $0.94, traded as high as $0.94 and as low as $0.94, and closed at $0.94. Trading volume was a total of 0 shares. On April 02, 2019, AST opened at $0.94, traded as high as $0.94 and as low as $0.94, and closed at $0.94. Trading volume was a total of 0 shares.

AST Historical Stock Prices By Date:

AST historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AST shares, starting with a $10,000 purchase of AST, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/22/2014
End date: 04/02/2019
Start price/share: $3.66
End price/share: $0.94
Dividends collected/share: $0.00
Total return: -74.18%
Average Annual Total Return: -25.04%
Starting investment: $10,000.00
Ending investment: $2,581.49
Years: 4.70
Date Open High Low Close Volume
03/27/2019 $0.94 $0.94 $0.94 $0.94 0
03/28/2019 $0.94 $0.94 $0.94 $0.94 0
03/29/2019 $0.94 $0.94 $0.94 $0.94 0
04/01/2019 $0.94 $0.94 $0.94 $0.94 0
04/02/2019 $0.94 $0.94 $0.94 $0.94 0
Asterias Biotherapeutics is a clinical-stage biotechnology company. Co. is engaged in developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer. Co. has three clinical stage programs: AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in a Phase 1/2a clinical trial for spinal cord injuries; AST-VAC2, a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for which a clinical trial in non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy for the treatment of Acute Myeloid Leukemia.
Date Close
03/27/2019$0.94
03/28/2019$0.94
03/29/2019$0.94
04/01/2019$0.94
04/02/2019$0.94
AST is categorized under the Healthcare sector; below are some other companies in the same sector:

ASTM Historical Stock Prices
ASTX Historical Stock Prices
ATEC Historical Stock Prices
ATHX Historical Stock Prices
ATNM Historical Stock Prices
ATNX Historical Stock Prices
ATOS Historical Stock Prices
ATRA Historical Stock Prices
ATRC Historical Stock Prices
ATRI Historical Stock Prices

Email EnvelopeFree AST Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


AST Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.